Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2017

25.05.2017 | Original Article

Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel

verfasst von: Firas Rinawi, Amit Assa, Husam Bashir, Sarit Peleg, Raanan Shamir

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Data on inflammatory bowel disease (IBD) phenotypes among the Arab population in Israel or in the neighboring Arab countries is scarce.

Aim

We aimed to assess differences in disease phenotype among Arab and Jewish children living in Israel.

Methods

We performed a retrospective chart review of pediatric IBD cases, which were diagnosed at the Schneider Children’s Medical Center and Ha’Emek Medical Center in Israel between 2000 and 2014. Demographic, clinical, and phenotypic variables were compared between Arabs and Jews from Eastern (Sephardic) and Western (Ashkenazi) origin.

Results

Seventy-one Arab children with IBD were compared with 165 Ashkenazi and 158 Sephardic Jewish children. Age and gender did not differ between groups. Sephardic and Ashkenazi Jewish Crohn’s disease (CD) patients had significantly more stenotic behavior (24 and 26 vs. 5%, p = 0.03) and less fistulzing perianal disease (15 and 11 vs. 31%, p = 0.014) compared with Arab patients. Arab children with ulcerative colitis (UC) had more severe disease at diagnosis compared to Sephardic and Ashkenazi Jews reflected by higher Pediatric UC Activity Index (45 vs. 35 and 35, respectively, p = 0.03). Arab patients had significantly lower proportion of anti-Saccharomyces cerevisiae antibodies positivity (in CD) and perinuclear anti-neutrophil cytoplasmic antibodies positivity (in UC) than both Sephardic and Ashkenazi Jewish children (23 vs. 53 and 65%, p = 0.002 and 35 vs. 60 and 75%, respectively, p = 0.002).

Conclusion

Arab and Jewish children with IBD differ in disease characteristics and severity. Whether genetic or environmental factors are the cause for these differences is yet to be determined.
Literatur
1.
Zurück zum Zitat Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423–439.CrossRefPubMed Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2011;17:423–439.CrossRefPubMed
2.
Zurück zum Zitat Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. (e42; quiz e30).CrossRefPubMed Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54. (e42; quiz e30).CrossRefPubMed
3.
Zurück zum Zitat Levi Z, Shamiss A, Fraser GM, et al. The increasing prevalence of inflammatory bowel diseases among Jewish adolescents and the sociodemographic factors associated with diagnosis. Inflamm Bowel Dis. 2013;19:1867–1871.PubMed Levi Z, Shamiss A, Fraser GM, et al. The increasing prevalence of inflammatory bowel diseases among Jewish adolescents and the sociodemographic factors associated with diagnosis. Inflamm Bowel Dis. 2013;19:1867–1871.PubMed
4.
Zurück zum Zitat Odes HS, Fraser D, Krawiec J. Inflammatory bowel disease in migrant and native Jewish populations of southern Israel. Scand J Gastroenterol Suppl. 1989;170:36–38. (discussion 50-35).CrossRefPubMed Odes HS, Fraser D, Krawiec J. Inflammatory bowel disease in migrant and native Jewish populations of southern Israel. Scand J Gastroenterol Suppl. 1989;170:36–38. (discussion 50-35).CrossRefPubMed
5.
Zurück zum Zitat Fireman Z, Grossman A, Lilos P, et al. Epidemiology of Crohn’s disease in the Jewish population of central Israel, 1970–1980. Am J Gastroenterol. 1989;84:255–258.PubMed Fireman Z, Grossman A, Lilos P, et al. Epidemiology of Crohn’s disease in the Jewish population of central Israel, 1970–1980. Am J Gastroenterol. 1989;84:255–258.PubMed
6.
Zurück zum Zitat Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of southern Israel 1961–1985: epidemiological and clinical study. Gut. 1987;28:1630–1636.CrossRefPubMedPubMedCentral Odes HS, Fraser D, Krawiec J. Ulcerative colitis in the Jewish population of southern Israel 1961–1985: epidemiological and clinical study. Gut. 1987;28:1630–1636.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Grossman A, Fireman Z, Lilos P, et al. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970–1980. Hepatogastroenterology. 1989;36:193–197.PubMed Grossman A, Fireman Z, Lilos P, et al. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970–1980. Hepatogastroenterology. 1989;36:193–197.PubMed
8.
Zurück zum Zitat Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 2000;95:693–698.CrossRefPubMed Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 2000;95:693–698.CrossRefPubMed
9.
Zurück zum Zitat Birkenfeld S, Zvidi I, Hazazi R, et al. The prevalence of ulcerative colitis in Israel: a twenty-year survey. J Clin Gastroenterol. 2009;43:743–746.CrossRefPubMed Birkenfeld S, Zvidi I, Hazazi R, et al. The prevalence of ulcerative colitis in Israel: a twenty-year survey. J Clin Gastroenterol. 2009;43:743–746.CrossRefPubMed
10.
Zurück zum Zitat Odes HS, Locker C, Neumann L, et al. Epidemiology of Crohn’s disease in southern Israel. Am J Gastroenterol. 1994;89:1859–1862.PubMed Odes HS, Locker C, Neumann L, et al. Epidemiology of Crohn’s disease in southern Israel. Am J Gastroenterol. 1994;89:1859–1862.PubMed
11.
Zurück zum Zitat Zvidi I, Hazazi R, Birkenfeld S, et al. The prevalence of Crohn’s disease in Israel: a 20-year survey. Dig Dis Sci. 2009;54:848–852.CrossRefPubMed Zvidi I, Hazazi R, Birkenfeld S, et al. The prevalence of Crohn’s disease in Israel: a 20-year survey. Dig Dis Sci. 2009;54:848–852.CrossRefPubMed
12.
Zurück zum Zitat Odes HS, Fraser D, Krugliak P, et al. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut. 1991;32:1024–1026.CrossRefPubMedPubMedCentral Odes HS, Fraser D, Krugliak P, et al. Inflammatory bowel disease in the Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut. 1991;32:1024–1026.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Zvidi I, Fraser GM, Niv Y, et al. The prevalence of inflammatory bowel disease in an Israeli Arab population. J Crohns Colitis. 2013;7:e159–e163.CrossRefPubMed Zvidi I, Fraser GM, Niv Y, et al. The prevalence of inflammatory bowel disease in an Israeli Arab population. J Crohns Colitis. 2013;7:e159–e163.CrossRefPubMed
14.
Zurück zum Zitat Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the united states: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22:2023–2040.CrossRefPubMed Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the united states: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22:2023–2040.CrossRefPubMed
15.
Zurück zum Zitat Fidder HH, Avidan B, Lahav M, et al. Clinical and demographic characterization of Jewish Crohn’s disease patients in Israel. J Clin Gastroenterol. 2003;36:8–12.CrossRefPubMed Fidder HH, Avidan B, Lahav M, et al. Clinical and demographic characterization of Jewish Crohn’s disease patients in Israel. J Clin Gastroenterol. 2003;36:8–12.CrossRefPubMed
16.
Zurück zum Zitat Bar-Gil Shitrit A, Koslowsky B, Kori M, et al. Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel. Inflamm Bowel Dis. 2015;21:631–635.CrossRefPubMed Bar-Gil Shitrit A, Koslowsky B, Kori M, et al. Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel. Inflamm Bowel Dis. 2015;21:631–635.CrossRefPubMed
17.
Zurück zum Zitat Rinawi F, Assa A, Hartman C, et al. Evolution of disease phenotype in pediatric-onset Crohn’s disease after more than 10 years follow up-Cohort study. Dig Liver Dis. 2016;48:1444.CrossRefPubMed Rinawi F, Assa A, Hartman C, et al. Evolution of disease phenotype in pediatric-onset Crohn’s disease after more than 10 years follow up-Cohort study. Dig Liver Dis. 2016;48:1444.CrossRefPubMed
18.
Zurück zum Zitat Shaoul R, Karban A, Reif S, et al. Disease behavior in children with Crohn’s disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009;54:142–150.CrossRefPubMed Shaoul R, Karban A, Reif S, et al. Disease behavior in children with Crohn’s disease: the effect of disease duration, ethnicity, genotype, and phenotype. Dig Dis Sci. 2009;54:142–150.CrossRefPubMed
19.
Zurück zum Zitat de Bie CI, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS registry. Inflamm Bowel Dis. 2013;19:378–385.CrossRefPubMed de Bie CI, Paerregaard A, Kolacek S, et al. Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS registry. Inflamm Bowel Dis. 2013;19:378–385.CrossRefPubMed
20.
Zurück zum Zitat Freeman HJ. Natural history and clinical behavior of Crohn’s disease extending beyond two decades. J Clin Gastroenterol. 2003;37:216–219.CrossRefPubMed Freeman HJ. Natural history and clinical behavior of Crohn’s disease extending beyond two decades. J Clin Gastroenterol. 2003;37:216–219.CrossRefPubMed
21.
Zurück zum Zitat Siddique I, Alazmi W, Al-Ali J, et al. Clinical epidemiology of Crohn’s disease in Arabs based on the Montreal classification. Inflamm Bowel Dis. 2012;18:1689–1697.CrossRefPubMed Siddique I, Alazmi W, Al-Ali J, et al. Clinical epidemiology of Crohn’s disease in Arabs based on the Montreal classification. Inflamm Bowel Dis. 2012;18:1689–1697.CrossRefPubMed
22.
Zurück zum Zitat Siala N, Benzarti A, Boukthir S, et al. Pediatric Crohn’s disease in Tunisia. Tunis Med. 2013;91:715–723.PubMed Siala N, Benzarti A, Boukthir S, et al. Pediatric Crohn’s disease in Tunisia. Tunis Med. 2013;91:715–723.PubMed
23.
24.
Zurück zum Zitat Kappelman MD, Crandall WV, Colletti RB, et al. Short pediatric Crohn’s disease activity index for quality improvement and observational research. Inflamm Bowel Dis. 2011;17:112–117.CrossRefPubMed Kappelman MD, Crandall WV, Colletti RB, et al. Short pediatric Crohn’s disease activity index for quality improvement and observational research. Inflamm Bowel Dis. 2011;17:112–117.CrossRefPubMed
25.
Zurück zum Zitat Shepanski MA, Markowitz JE, Mamula P, et al. Is an abbreviated Pediatric Crohn’s Disease Activity Index better than the original? J Pediatr Gastroenterol Nutr. 2004;39:68–72.CrossRefPubMed Shepanski MA, Markowitz JE, Mamula P, et al. Is an abbreviated Pediatric Crohn’s Disease Activity Index better than the original? J Pediatr Gastroenterol Nutr. 2004;39:68–72.CrossRefPubMed
26.
Zurück zum Zitat Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.CrossRefPubMed Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.CrossRefPubMed
27.
Zurück zum Zitat Turner D, Hyams J, Markowitz J, et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009;15:1218–1223.CrossRefPubMed Turner D, Hyams J, Markowitz J, et al. Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009;15:1218–1223.CrossRefPubMed
28.
Zurück zum Zitat Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.CrossRefPubMed Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.CrossRefPubMed
29.
Zurück zum Zitat Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.PubMed Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.PubMed
30.
Zurück zum Zitat Karban A, Atia O, Leitersdorf E, et al. The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn’s disease: lessons from the Israeli Arab Crohn’s disease cohort. Dig Dis Sci. 2005;50:1692–1697.CrossRefPubMed Karban A, Atia O, Leitersdorf E, et al. The relation between NOD2/CARD15 mutations and the prevalence and phenotypic heterogeneity of Crohn’s disease: lessons from the Israeli Arab Crohn’s disease cohort. Dig Dis Sci. 2005;50:1692–1697.CrossRefPubMed
31.
Zurück zum Zitat Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.CrossRefPubMed Basu D, Lopez I, Kulkarni A, et al. Impact of race and ethnicity on inflammatory bowel disease. Am J Gastroenterol. 2005;100:2254–2261.CrossRefPubMed
32.
Zurück zum Zitat Lawrance IC, Murray K, Hall A, et al. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol. 2004;99:2186–2194.CrossRefPubMed Lawrance IC, Murray K, Hall A, et al. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am J Gastroenterol. 2004;99:2186–2194.CrossRefPubMed
33.
Zurück zum Zitat Hadrich I, Vandewalle P, Cheikhrouhou F, et al. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn’s disease patients, their relatives or associated clinical factors. Scand J Gastroenterol. 2007;42:717–725.CrossRefPubMed Hadrich I, Vandewalle P, Cheikhrouhou F, et al. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn’s disease patients, their relatives or associated clinical factors. Scand J Gastroenterol. 2007;42:717–725.CrossRefPubMed
34.
Zurück zum Zitat Alvarez-Lobos M, Arostegui JI, Sans M, et al. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg. 2005;242:693–700.CrossRefPubMedPubMedCentral Alvarez-Lobos M, Arostegui JI, Sans M, et al. Crohn’s disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg. 2005;242:693–700.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Weiss B, Shamir R, Bujanover Y, et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn’s disease. J Pediatr. 2004;145:208–212.CrossRefPubMed Weiss B, Shamir R, Bujanover Y, et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn’s disease. J Pediatr. 2004;145:208–212.CrossRefPubMed
36.
Zurück zum Zitat Al-Mofarreh MA, Al Mofleh IA, Al-Teimi IN, et al. Crohn’s disease in a Saudi outpatient population: is it still rare? Saudi J Gastroenterol. 2009;15:111–116.CrossRefPubMedPubMedCentral Al-Mofarreh MA, Al Mofleh IA, Al-Teimi IN, et al. Crohn’s disease in a Saudi outpatient population: is it still rare? Saudi J Gastroenterol. 2009;15:111–116.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Guariso G, Gasparetto M, Visona Dalla Pozza LV, et al. Inflammatory bowel disease developing in paediatric and adult age. J Pediatr Gastroenterol Nutr. 2010;51:698–707.CrossRefPubMed Guariso G, Gasparetto M, Visona Dalla Pozza LV, et al. Inflammatory bowel disease developing in paediatric and adult age. J Pediatr Gastroenterol Nutr. 2010;51:698–707.CrossRefPubMed
38.
Zurück zum Zitat Karban A, Itay M, Davidovich O, et al. Risk factors for perianal Crohn’s disease: the role of genotype, phenotype, and ethnicity. Am J Gastroenterol. 2007;102:1702–1708.CrossRefPubMed Karban A, Itay M, Davidovich O, et al. Risk factors for perianal Crohn’s disease: the role of genotype, phenotype, and ethnicity. Am J Gastroenterol. 2007;102:1702–1708.CrossRefPubMed
39.
Zurück zum Zitat Butt MT, Bener A, Al-Kaabi S, et al. Clinical characteristics of Crohn’s disease in Qatar. Saudi Med J. 2005;26:1796–1799.PubMed Butt MT, Bener A, Al-Kaabi S, et al. Clinical characteristics of Crohn’s disease in Qatar. Saudi Med J. 2005;26:1796–1799.PubMed
40.
Zurück zum Zitat Toonisi TS. Crohn’s disease in children from the western region of Saudi Arabia. J Gastroenterol Hepatol. 1993;8:462–464.CrossRefPubMed Toonisi TS. Crohn’s disease in children from the western region of Saudi Arabia. J Gastroenterol Hepatol. 1993;8:462–464.CrossRefPubMed
41.
Zurück zum Zitat Khalifa SE, Mudawi HM, Fedail SS. Presentation and management outcome of inflammatory bowel disease in Sudan. Trop Gastroenterol. 2005;26:194–196.PubMed Khalifa SE, Mudawi HM, Fedail SS. Presentation and management outcome of inflammatory bowel disease in Sudan. Trop Gastroenterol. 2005;26:194–196.PubMed
42.
Zurück zum Zitat Radhakrishnan S, Zubaidi G, Daniel M, et al. Ulcerative colitis in Oman. A prospective study of the incidence and disease pattern from 1987 to 1994. Digestion. 1997;58:266–270.CrossRefPubMed Radhakrishnan S, Zubaidi G, Daniel M, et al. Ulcerative colitis in Oman. A prospective study of the incidence and disease pattern from 1987 to 1994. Digestion. 1997;58:266–270.CrossRefPubMed
43.
Zurück zum Zitat Abdul-Baki H, ElHajj I, El-Zahabi LM, et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2007;13:475–480.CrossRefPubMed Abdul-Baki H, ElHajj I, El-Zahabi LM, et al. Clinical epidemiology of inflammatory bowel disease in Lebanon. Inflamm Bowel Dis. 2007;13:475–480.CrossRefPubMed
44.
Zurück zum Zitat Al-Qabandi WA, Buhamrah EK, Hamadi KA, et al. Inflammatory bowel disease in children, an evolving problem in Kuwait. Saudi J Gastroenterol. 2011;17:323–327.CrossRefPubMedPubMedCentral Al-Qabandi WA, Buhamrah EK, Hamadi KA, et al. Inflammatory bowel disease in children, an evolving problem in Kuwait. Saudi J Gastroenterol. 2011;17:323–327.CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Green MS. Differences between Israeli Jews and Arabs in morbidity and mortality rates for diseases potentially associated with dietary risk factors. Public Health Rev. 1998;26:31–40.PubMed Green MS. Differences between Israeli Jews and Arabs in morbidity and mortality rates for diseases potentially associated with dietary risk factors. Public Health Rev. 1998;26:31–40.PubMed
46.
Zurück zum Zitat Karban A, Krivoy N, Elkin H, et al. Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency. Dig Dis Sci. 2011;56:2081–2087.CrossRefPubMed Karban A, Krivoy N, Elkin H, et al. Non-Jewish Israeli IBD patients have significantly higher glutathione S-transferase GSTT1-null frequency. Dig Dis Sci. 2011;56:2081–2087.CrossRefPubMed
47.
Zurück zum Zitat Cabral VL, Miszputen SJ, Catapani WR. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology. 2003;50:412–415.PubMed Cabral VL, Miszputen SJ, Catapani WR. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease. Hepatogastroenterology. 2003;50:412–415.PubMed
Metadaten
Titel
Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel
verfasst von
Firas Rinawi
Amit Assa
Husam Bashir
Sarit Peleg
Raanan Shamir
Publikationsdatum
25.05.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4623-x

Weitere Artikel der Ausgabe 8/2017

Digestive Diseases and Sciences 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.